OR5AC2 is a class II olfactory receptor localized to human chromosome 3 . It shares the seven-transmembrane domain structure characteristic of GPCRs and is involved in recognizing odorant molecules, initiating neuronal responses that contribute to the sense of smell . The recombinant version is produced for research purposes to study its ligand-binding properties, structural dynamics, and role in olfactory signaling.
Recombinant OR5AC2 is synthesized using heterologous expression systems to ensure high purity and functionality. Key production details include:
The protein is typically stored at -20°C or -80°C to maintain stability, with a shelf life of 6–12 months depending on storage conditions .
Recombinant OR5AC2 is utilized in:
Ligand Screening: Identifying odorants or synthetic compounds that activate or inhibit the receptor .
Structural Studies: Investigating GPCR dynamics via homology modeling .
Diagnostic Assays: Quantifying OR5AC2 in biological samples using ELISA kits (detection range: 0.156–10 ng/ml) .
While specific ligands for OR5AC2 remain uncharacterized, studies on olfactory receptors broadly reveal:
Combinatorial Coding: Multiple receptors contribute to detecting a single odorant .
Species-Specific Variations: Humans have ~400 functional olfactory receptors, fewer than mice (~1,400), reflecting evolutionary adaptations .
Disease Links: Olfactory receptor dysfunction is implicated in neurodegenerative disorders like Alzheimer’s .
Current challenges include deorphanizing OR5AC2 (identifying its ligands) and resolving its 3D structure. Advances in cryo-EM and high-throughput screening may accelerate these efforts .
OR5AC2 (olfactory receptor family 5 subfamily AC member 2) is a protein-coding gene located on chromosome 3 in humans. It encodes an olfactory receptor protein involved in the sense of smell, triggering neuronal responses that lead to odor perception. OR5AC2 belongs to the G-protein-coupled receptor 1 family, the largest gene superfamily in the human genome . This receptor, also known as HSA1, functions as a chemoreceptor expressed in the cell membranes of olfactory receptor neurons . Like other olfactory receptors, OR5AC2 is part of the class A rhodopsin-like family of G protein-coupled receptors (GPCRs) that form the largest multigene family in vertebrates, with humans possessing approximately 400 functional olfactory receptor genes .
Distinguishing OR5AC2 from other olfactory receptors requires multiple complementary approaches:
Genetic identification: Use of specific PCR primers that target unique sequences in the OR5AC2 gene
Epitope tagging: Addition of unique tags (e.g., FLAG, HA) to the N-terminus or C-terminus of the receptor for antibody detection
Fluorescent protein fusion: Creating OR5AC2-GFP fusion proteins for visualization and tracking, similar to methods used for other olfactory receptors
Antibody-based detection: Using OR5AC2-specific antibodies for immunohistochemistry or Western blotting
Functional deorphanization: Characterizing unique response profiles to odorant panels
When using these methods, it is essential to include appropriate controls with other olfactory receptors to confirm specificity, as cross-reactivity is common due to sequence similarities within the olfactory receptor family .
Several expression systems have been employed for olfactory receptors, with varying success rates for producing functional proteins:
| Expression System | Advantages | Disadvantages | Yield | Functional Status |
|---|---|---|---|---|
| HEK293T cells | Mammalian post-translational modifications, Compatible with GPCR folding | Moderate expression levels | 10^5-10^6 receptors/cell | Often functional |
| Hana3A cells | Enhanced surface trafficking via RTP1-4 and REEP1 co-expression | Specialized cell line | 10^6-10^7 receptors/cell | Highly functional |
| Sf9 insect cells | High expression levels | Different lipid composition | 10^7-10^8 receptors/cell | Variable functionality |
| Cell-free systems | Rapid production, Avoids cell toxicity | Limited post-translational modifications | Variable | Requires refolding |
For OR5AC2 specifically, mammalian expression systems using Hana3A cells (which express accessory factors like RTP1, RTP2, and olfactory G-proteins) typically produce the most functional receptor protein . When using any heterologous expression system, co-expression with chaperone proteins such as receptor-transporting proteins (RTPs) significantly improves surface expression and functionality of the receptor .
Olfactory receptors, including OR5AC2, are notoriously difficult to express due to poor trafficking to the plasma membrane. Researchers can employ several strategies to overcome these challenges:
Co-expression with accessory proteins: Include RTPs (Receptor Transporting Proteins), REEPs (Receptor Expression Enhancing Proteins), and Ric-8B to enhance surface expression
N-terminal modifications:
Addition of the first 20 amino acids of rhodopsin (Rho-tag)
Removal of N-glycosylation sites
Codon optimization for the expression system
Temperature modulation: Expression at lower temperatures (30°C instead of 37°C) can improve folding
Detergent selection: Use of mild detergents (DDM, LMNG, or GDN) for membrane extraction
Validation of functional expression should include both surface localization assays and functional response measurements to confirm the receptor maintains its native conformation and signaling capabilities .
Multiple complementary approaches can be used to identify and validate OR5AC2 ligands:
Calcium imaging assays: Cells expressing OR5AC2 are loaded with calcium-sensitive dyes (e.g., Fura-2 AM), and changes in intracellular calcium are measured upon odorant application.
cAMP reporter assays: Since olfactory receptors couple to Gαolf (stimulating adenylyl cyclase), cAMP production can be measured using:
CRE-luciferase reporters
FRET-based cAMP sensors (e.g., EPAC-based sensors)
GloSensor assays
Electrophysiological recordings: Patch-clamp techniques can measure channel activity downstream of OR activation.
Impedance measurements: Real-time cell analysis systems can detect morphological changes following receptor activation.
The M2OR database contains experimental data on OR-molecule interactions and can serve as a valuable resource for designing new ligand screening experiments or comparing results . When conducting these assays, it's crucial to include both positive controls (known GPCR ligands) and negative controls (cells without receptor expression) to validate assay performance and specificity .
Determining OR5AC2 specificity and sensitivity requires rigorous experimental design and data analysis:
Concentration-response relationships:
Test increasing concentrations of odorants (typically 10^-9 to 10^-3 M)
Calculate EC50 values to quantify potency
Determine efficacy (maximum response) for each ligand
Structure-activity relationships:
Test structurally related compounds to map the pharmacophore
Analyze how molecular features (functional groups, stereochemistry) affect response
Cross-receptor activation profiles:
Test the same odorants on related olfactory receptors
Calculate selectivity indices (ratio of EC50 values)
Temporal response characteristics:
Data normalization approaches:
| Normalization Method | Advantages | Disadvantages |
|---|---|---|
| % of maximum response | Compares relative efficacy | Requires maximum stimulation |
| % of standard odorant | Allows cross-experiment comparison | Depends on standard stability |
| Z-score transformation | Accounts for baseline variability | Abstract units |
| ΔF/F for calcium imaging | Controls for dye loading | Sensitive to baseline fluctuations |
Research has shown that olfactory perceptions depend on odorant concentration, with changes in concentration potentially leading to different perceptions of hedonicity or olfactory quality . Therefore, when characterizing OR5AC2, it's essential to test multiple concentrations and carefully report both screening concentrations and EC50 values for all experimental data .
Copy number variations (CNVs) significantly impact the olfactory receptor gene family, including OR5AC2:
Research using high-resolution oligonucleotide tiling microarrays has revealed that OR genomic loci are frequently affected by CNVs, creating a mosaic of OR dosages across individuals . These variations have functional consequences:
Expression level differences: More gene copies typically lead to higher expression levels
Functional redundancy: CNVs may provide compensatory mechanisms when some receptor variants are non-functional
Population-specific olfactory capabilities: Different populations show distinct patterns of OR CNVs
Studies have shown that approximately 50% of OR CNVs involve more than one OR gene, with the largest CNV spanning 11 loci . Interestingly, CNVs are more frequent among OR pseudogenes than among intact genes, presumably due to both selective constraints and CNV formation biases .
For research involving OR5AC2, it's crucial to:
Genotype study participants for OR5AC2 CNVs
Account for copy number in expression analyses
Consider CNVs when interpreting population differences in odor perception
The enrichment of CNVs among ORs with a close human paralog or lacking a one-to-one ortholog in chimpanzee suggests ongoing evolutionary dynamics that may affect OR5AC2 function across human populations .
Several computational approaches can help predict OR5AC2 ligand interactions:
Molecular docking simulations: Virtual screening of odorant libraries
Identifies potential binding modes and interaction energies
Software options include AutoDock, DOCK, and Glide
Should be validated with experimental mutagenesis
Machine learning approaches:
Evolutionary analysis:
Identification of positively selected sites likely involved in ligand binding
Conservation analysis across species to identify functionally important residues
Comparison with related ORs that have known ligands
QM/MM methods: Quantum mechanics/molecular mechanics simulations to model electronic interactions in the binding site
These computational predictions should guide experimental designs, particularly site-directed mutagenesis studies to validate the predicted binding sites. The M2OR database, which contains experimental data from 42 scientific articles and information about OR-molecule interactions, is a valuable resource for training and validating these computational models .
OR5AC2 can be engineered into various biosensor platforms for detecting specific odorants:
Cell-based biosensors:
Engineered cells expressing OR5AC2 coupled to reporter systems
Advantages: Maintain native receptor environment and signal amplification
Limitations: Require cell culture facilities, shorter shelf life
Solid-state biosensors:
Immobilized OR5AC2 on field-effect transistors or quartz crystal microbalance devices
Advantages: Portable, rapid response, no cellular components needed
Limitations: Reduced sensitivity, receptor stability issues
Synthetic biology approaches:
Engineering yeast or bacteria to express OR5AC2 and produce visible output signals
Creating cell-free systems with reconstituted OR5AC2 signaling components
Potential applications:
| Application | Target Analytes | Detection Method | Sensitivity |
|---|---|---|---|
| Food quality | Spoilage compounds | Optical/electrical | ppb-ppm |
| Environmental | Pollutants, toxins | Electrical/mass-based | ppt-ppb |
| Medical diagnostics | Disease biomarkers | Fluorescence/electrical | Variable |
| Security | Explosives, drugs | Array-based patterns | ppb |
These biosensor applications require careful optimization of receptor stability, as maintaining the native conformation of OR5AC2 outside the cell membrane is challenging. Strategies like directed evolution to improve stability, coupling with nanomaterials, and optimization of immobilization methods can help overcome these limitations .
Understanding OR5AC2's role in olfactory coding requires considering several key principles:
By studying OR5AC2 in this broader context, researchers gain insights into how individual receptors contribute to the complex process of odor perception and discrimination .
Research involving recombinant OR5AC2 must comply with the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules :
Definition and scope:
The guidelines apply to: (i) molecules constructed by joining nucleic acid molecules that can replicate in a living cell; (ii) nucleic acid molecules that are synthesized or amplified and can base pair with naturally occurring nucleic acid molecules; and (iii) molecules that result from replication of those described in (i) or (ii)
This includes work with recombinant OR5AC2 expression vectors and cell lines
Institutional oversight requirements:
Research must be approved by an Institutional Biosafety Committee (IBC)
Principal investigators must submit detailed protocols describing:
Vector construction
Expression systems
Containment procedures
Risk assessment
Biosafety level determination:
| Research Activity | Typical BSL Level | Key Requirements |
|---|---|---|
| Plasmid construction | BSL-1 | Standard microbiological practices |
| Mammalian cell expression | BSL-2 | Biological safety cabinet, limited access |
| Viral vector delivery | BSL-2+ | Enhanced practices, dedicated equipment |
Training requirements:
All personnel must be trained in biosafety procedures
Documentation of training must be maintained
Annual refresher training is typically required
Importantly, any changes to approved protocols must be submitted for review before implementation. For experiments involving the administration of recombinant OR5AC2 to research participants (human gene transfer), additional regulatory approvals are required, and no such experiment shall be initiated until IBC approval has been obtained and all applicable regulatory authorizations and approvals have been secured .
Ensuring the quality and consistency of recombinant OR5AC2 preparations requires rigorous quality control measures:
Expression verification:
Western blot analysis with anti-OR5AC2 or anti-tag antibodies
Mass spectrometry confirmation of protein identity
qRT-PCR for mRNA expression levels
Purity assessment:
Functional validation:
Ligand binding assays to confirm proper folding
G-protein coupling assays (e.g., [35S]GTPγS binding)
Calcium mobilization or cAMP production in response to known agonists
Comparison with positive control receptors
Stability testing:
Thermal stability assays (differential scanning fluorimetry)
Time-course activity measurements
Freeze-thaw stability testing
Storage recommendations:
Batch consistency measures:
| Parameter | Method | Acceptance Criteria |
|---|---|---|
| Protein concentration | BCA or Bradford assay | Within 10% of specification |
| Activity | Dose-response to standard ligand | EC50 within 3-fold of reference |
| Purity | SDS-PAGE densitometry | ≥85% |
| Endotoxin | LAL assay | <0.1 EU/μg protein |
| Aggregation | DLS or SEC | <10% high molecular weight species |
These quality control measures ensure that experimental results using recombinant OR5AC2 are reproducible and reliable. Particularly for functional studies, it's crucial to note that OR responses can show assay-dependent bias . Therefore, standardization of expression systems, assay conditions, and quality control parameters is essential for meaningful comparison of results across different studies .
Optimizing experimental designs for OR5AC2-ligand interaction studies requires careful consideration of multiple factors:
Experimental controls:
Positive controls: Use well-characterized ORs with known ligands (e.g., OR1A1 with citronellal)
Negative controls: Mock-transfected cells and cells expressing unrelated ORs
Vehicle controls: Account for solvent effects (especially with DMSO or ethanol)
Odorant handling:
Prepare fresh stock solutions in appropriate solvents (typically DMSO or ethanol)
Use gas-tight containers to prevent odorant volatilization
Control for odorant degradation with analytical verification
Standardize delivery methods to ensure reproducible concentrations
Statistical design:
Minimum of 3-6 biological replicates
Technical triplicates for each biological replicate
Power analysis to determine appropriate sample size
Randomized plate layouts to minimize position effects
Include internal standards for plate-to-plate normalization
Temporal considerations:
Research has shown that olfactory perception is dependent on odorant concentration, with changes in concentration potentially leading to different perceptions . Therefore, comprehensive concentration-response relationships are essential for accurately characterizing OR5AC2-ligand interactions .
Research with olfactory receptors, including OR5AC2, presents several challenges that require specific troubleshooting approaches:
| Challenge | Potential Causes | Troubleshooting Strategies |
|---|---|---|
| Poor receptor expression | Inefficient trafficking, Protein misfolding, Toxicity | Co-express with RTP1S, REEP1, and Ric-8B; Use Rho-tag fusion; Lower expression temperature; Test different promoters |
| High background in functional assays | Endogenous receptor expression, Non-specific responses | Use receptor-null cell lines; Include mock-transfected controls; Validate with multiple assay formats |
| Inconsistent responses | Receptor desensitization, Variable expression levels, Compound degradation | Standardize exposure times; Use inducible expression systems; Prepare fresh compounds; Verify compound stability |
| Non-reproducible ligand identification | Assay-dependent bias, Compound impurities, Cellular context differences | Test in multiple assay systems; Use analytical-grade compounds; Maintain consistent cell culture conditions |
| Difficulties in deorphanization | Limited odorant screening libraries, Narrow concentration range, Missing cofactors | Expand chemical diversity in screening; Test wide concentration ranges; Consider native nasal environment factors |
Key methodological considerations to address these issues include:
Expression system selection: Different cell lines may show variable results. The M2OR database highlights that functional studies of ORs have relied on various bioassays, including native olfactory sensory neurons and different heterologous expression systems, and responses can show assay-dependent bias .
Signal-to-background optimization:
Use serum starvation to reduce basal activity
Optimize cell density for maximal signal
Consider signal amplification strategies (e.g., chimeric G-proteins)
Reproducibility measures:
Document detailed experimental conditions (temperature, humidity, etc.)
Record passage number of cells used
Standardize transfection efficiency measurements
Implement rigorous data normalization protocols
By anticipating these challenges and implementing appropriate controls and validation strategies, researchers can increase the reliability and reproducibility of their OR5AC2 studies .
Several cutting-edge technologies show promise for enhancing OR5AC2 research:
Cryo-EM and structural biology:
Recent advances in cryo-electron microscopy may enable direct visualization of OR5AC2 structure
Determining the 3D structure would revolutionize understanding of ligand binding mechanisms
Nanobody stabilization approaches could help capture different conformational states
Single-cell omics:
Single-cell RNA sequencing to map OR5AC2 expression patterns in olfactory epithelium
Spatial transcriptomics to understand the distribution of OR5AC2-expressing neurons
Integration with functional data to correlate expression with odor responses
Advanced imaging techniques:
Super-resolution microscopy to visualize OR5AC2 localization and trafficking
Calcium imaging with genetically encoded calcium indicators in OR5AC2-expressing neurons
Multi-photon imaging in intact olfactory epithelium
AI and computational approaches:
Deep learning models to predict OR5AC2-ligand interactions
Integration of structural, genetic, and functional data through machine learning
Virtual screening of millions of compounds to identify novel ligands
The adaptation of olfactory receptor abundances for efficient coding suggests that receptor distribution may be tuned to maximize information about the olfactory environment . New technologies that can track these adaptations at cellular and molecular levels will provide deeper insights into how OR5AC2 contributes to olfactory perception in different contexts and environments .
Research on OR5AC2 has implications that extend beyond basic olfactory science:
Biomedical applications:
Development of olfactory-based diagnostic tools for diseases with olfactory signatures
Understanding mechanisms of anosmia and potential therapeutic approaches
Exploration of ectopic OR5AC2 expression in non-olfactory tissues and potential physiological roles
Environmental monitoring:
Creation of OR5AC2-based biosensors for detecting specific environmental chemicals
Arrays of olfactory receptors including OR5AC2 for "electronic nose" technologies
Remote sensing applications for hazardous environments
Evolutionary biology insights:
Synthetic biology platforms:
| Application | Description | Research Stage |
|---|---|---|
| Olfactory cell lines | Engineered cell lines expressing defined OR sets | Early development |
| Biosensing devices | Integrated OR5AC2-based detection systems | Proof of concept |
| Scent reproduction | Reverse engineering of complex scents | Theoretical |
| Metabolic engineering | Using ORs to detect metabolic products | Emerging |
Sensory neuroscience integration:
Understanding multimodal sensory integration
Investigating the relationship between genetic variation in OR5AC2 and perceptual differences
Exploring the role of efficient coding principles in other sensory systems
The unique challenges and characteristics of olfactory receptors—the largest gene family in the human genome with highly individualized variation patterns—provide a model system for understanding G-protein coupled receptor biology, evolution, and function . Research on OR5AC2 contributes to this broader understanding while also opening new avenues for biotechnological applications.